Live from the NIH registry
Studies recruiting near Surprise right now
Top 25 of 1,010 recruiting studies, sorted by proximity — each links to its official registry page
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Banner-University Medical Center Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Abbott Medical Devices
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Phoenix Children's Hospital — Phoenix, Arizona (27.1 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Vallywise Health Medical Center — Phoenix, Arizona (27.1 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (27.1 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
KRAS G12C Mutation, KRAS G12S Mutation
Phase 1
Interventional 140 participants sought
Mayo Clinic, Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Kumquat Biosciences Inc.
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
City of Hope - Phoenix — Goodyear, Arizona (17.8 mi)
· Sponsor: Hoffmann-La Roche
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Focal Onset Seizure, Primary Generalized Epilepsy
Phase 2
Interventional 50 participants sought
Praxis Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: Praxis Precision Medicines
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Phoenix, AZ — Phoenix, Arizona (27.1 mi)
· Sponsor: Mediar Therapeutics
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Research Solutions of Arizona — Litchfield Park, Arizona (14.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Tectonic Operating Company, Inc.
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
City of Hope — Phoenix, Arizona (27.1 mi)
· Sponsor: Immuneering Corporation
Evaluate the Safety and Clinical Activity of HH2853
FL Lymphoma, Epithelioid Sarcoma
Phase 1, Phase 2
Interventional 254 participants sought
Mayo Clinic — Phoenix, Arizona (27.1 mi)
· Sponsor: Haihe Biopharma Co., Ltd.
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
HonorHeath Scottsdale Osborn Medical Center — Phoenix, Arizona (27.1 mi)
· Sponsor: GT Medical Technologies, Inc.
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
Banner Research Institute — Sun City, Arizona (11.9 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 110 participants sought
Phoenix Children's Hospital /ID# 255766 — Phoenix, Arizona (27.1 mi)
· Sponsor: AbbVie
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Arizona Gynecology Consultants — Phoenix, Arizona (27.1 mi)
· Sponsor: Rejoni Inc.
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigator Site — Phoenix, Arizona (27.1 mi)
· Sponsor: Alkermes, Inc.
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Xenoscience — Phoenix, Arizona (27.1 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research — Sun City, Arizona (11.9 mi)
· Sponsor: Annovis Bio Inc.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Colorectal Cancer, Colorectal Cancer (CRC)
Phase 1
Interventional 80 participants sought
Mayo Clinic Arizona — Phoenix, Arizona (27.1 mi)
· Sponsor: Cartography Biosciences
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Severe Tricuspid Regurgitation
N/A
Interventional 1,186 participants sought
Abrazo Arizona Heart Hospital — Phoenix, Arizona (27.1 mi)
· Sponsor: Medtronic Cardiovascular
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 500 participants sought
Barrow Neurological Institute — Phoenix, Arizona (27.1 mi)
· Sponsor: Prilenia
Online Sleep Education for College Student's Sleep Health and Executive Functioning
Sleep, Executive Functioning
N/A
Interventional 300 participants sought
Northern Arizona University — Phoenix, Arizona (27.1 mi)
· Sponsor: Northern Arizona University